ASCO

Research in Review

Ovarian Cancer Associated With Out-of-Pocket Financial Burden

06/07/2017

JCP Editors

Patients receiving treatment for ovarian cancer experienced a significant out-of-pocket financial burden, due largely to cost disparities across treatment types and a lack of definitive treatment options, according...

...

06/07/2017

Journal of Clinical Pathways

Research in Review

Financial Conflicts of Interest Common Among Clinical Pathway Vendors

06/07/2017

JCP Editors

A majority of practitioners involved in clinical pathway development at three major oncology vendors received nonresearch general payments in 2015, according to research presented at the 2017 ASCO Annual Meeting...

A...

06/07/2017

Journal of Clinical Pathways

Research in Review

Metastatic Hormone-Na√Øve Prostate Cancer Effectively Treated With Combination Therapy

06/07/2017

JCP Editors

Groundbreaking results of a trial have shown that the combination of a new drug with androgen deprivation therapy (ADT) significantly improves overall survival (OS) and radiographic progression-free survival (PFS) in...

...

06/07/2017

Journal of Clinical Pathways

Research in Review

Advanced Melanoma Increases Psychological Burden in Patients

05/25/2017

JCP Editors

Stage III and IV melanoma may have a profound impact on patients’ distress burden, which requires further intervention strategies, according to research that will be presented at the 2017 ASCO Annual Meeting...

Stage...

05/25/2017

Journal of Clinical Pathways

Interview

The Shaping of Clinical Pathways Through User-Defined Value-Based Care

03/27/2017

JCP Editors

Journal of Clinical Pathways spoke with Alex W Bastian, MBA, strategic advisor, ASCO Value In Cancer Task Force, about how his role in the Task Force has impacted his views concerning...

...

03/27/2017

Journal of Clinical Pathways

Research in Review

Small Study Suggests Nivolumab Does Not Improve Outcomes in Patients With Lung Cancer and Liver Metastases

03/16/2017

JCP Editors

None of the patients in a study with lung cancer and hepatic metastases experienced an objective response in their liver tumors after anti-PD1 therapy, according to research presented at ASCO’s Society for...

None...

03/16/2017

Journal of Clinical Pathways

Research in Review

Lower Dosage of Prostate Cancer Drug Equally Effective When Taken With Low-Fat Meal

02/17/2017

JCP Editors

Taking one-fourth the recommended dose of a standard drug with a low-fat meal is as effective as taking the recommended dose on an empty stomach for patients with castration-resistant prostate cancer, according to...

Taking...

02/17/2017

Journal of Clinical Pathways

Interview

Clinical Pathways in Community Oncology: Assessing the Work of the American Society of Clinical Oncology Task Force on Clinical Pathways

02/13/2017

JCP Editors

Providers and practices across medical specialties have eagerly adopted clinical pathways in efforts to standardize care and achieve uniform outcomes. However, few disciplines have been as receptive to the concept of...

...

02/13/2017

Journal of Clinical Pathways

Interview

Clinical Pathways Through Quality Metrics: ASCO Quality Oncology Practice Initiative

12/13/2016

JCP Editors

The delivery of cancer care in the United States is rapidly evolving. Approximately 70% of US patients with cancer are treated at community oncology centers, but it has become increasingly common for stand-alone...

The...

12/13/2016

Journal of Clinical Pathways

The Oncology Practice Perspective

08/02/2016

JCP Editors

In order to address the oncologist’s perspective on clinical pathways, James N Frame, MD, FACP, Charleston Area Medical Center, talked about some of the concerns that oncology care providers have about using clinical...

In...

08/02/2016

Journal of Clinical Pathways